Crestwood Advisors Group LLC Lowers Stock Position in Mettler-Toledo International, Inc. (NYSE:MTD)

Crestwood Advisors Group LLC cut its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 3.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,348 shares of the medical instruments supplier's stock after selling 767 shares during the quarter. Crestwood Advisors Group LLC owned 0.12% of Mettler-Toledo International worth $28,753,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Edmond DE Rothschild Holding S.A. bought a new stake in shares of Mettler-Toledo International during the 4th quarter valued at approximately $44,000. Golden State Wealth Management LLC grew its holdings in Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after acquiring an additional 35 shares during the last quarter. Menard Financial Group LLC bought a new stake in Mettler-Toledo International during the 4th quarter worth approximately $67,000. Blue Trust Inc. grew its holdings in Mettler-Toledo International by 520.0% during the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after acquiring an additional 52 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its holdings in Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock worth $78,000 after acquiring an additional 8 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their target price for the stock from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Bank of America upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Wells Fargo & Company upped their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price objective for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $1,280.90.

Mettler-Toledo International Stock Down 0.1%

MTD traded down $0.82 during trading on Thursday, hitting $1,256.38. 92,141 shares of the company's stock were exchanged, compared to its average volume of 174,591. The business's 50 day moving average is $1,179.25 and its two-hundred day moving average is $1,193.87. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93. The stock has a market cap of $26.11 billion, a P/E ratio of 31.34, a PEG ratio of 3.75 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping the consensus estimate of $7.90 by $0.29. The firm had revenue of $883.74 million for the quarter, compared to the consensus estimate of $876.61 million. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The business's revenue was down 4.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $8.89 earnings per share. On average, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In other news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director owned 120 shares in the company, valued at $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.94% of the stock is currently owned by corporate insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.